Sandu Pharmaceuticals

Sandu Pharmaceuticals EBIT Margin

The EBIT Margin (Operating Margin) of Sandu Pharmaceuticals (524703.BO) as of Oct 31, 2026 is 3.87 %. In the previous year, EBIT Margin (Operating Margin) was 3.36 % — a change of 15.20% (higher).

EBIT Margin

3.87 %

YoY

15.20%

Last updated:

EBIT Margin (Operating Margin) of Sandu Pharmaceuticals is 2026 3.87 % . EBIT Margin (Operating Margin) of Sandu Pharmaceuticals was 2025 3.36 % . It decreases by 15.20% higher compared to the previous year.

For Sandu Pharmaceuticals, the operating (EBIT) margin of 3.9% is broadly stable versus 3.6% a few years ago.

The Sandu Pharmaceuticals EBIT Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Margin
Date
EBIT Margin
Jan 1, 2019
2.94 INR
Jan 1, 2020
1.86 INR
Jan 1, 2021
2.73 INR
Jan 1, 2022
3.58 INR
Jan 1, 2023
3.51 INR
Jan 1, 2024
3.17 INR
Jan 1, 2025
3.36 INR
Jan 1, 2026
3.87 INR
The Sandu Pharmaceuticals EBIT Margin history
YEAREBIT MarginYoY
3.87 %+15.20%
3.36 %+5.91%
3.17 %-9.66%
3.51 %-1.80%
3.58 %+31.21%
2.73 %+46.39%
1.86 %-36.74%
2.94 %-22.35%
3.79 %-25.39%
5.08 %-4.18%
5.31 %+24.43%
4.26 %-4.46%
4.46 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Sandu Pharmaceuticals Stock analysis

What does Sandu Pharmaceuticals do? Sandu Pharmaceuticals Ltd is a Mumbai-based company operating in the Consumer Staples sector, specifically within the consumer products industry. Listed on September 26, 1994, the firm manufactures and markets Ayurvedic medicines. Its product portfolio spans digestive health, immunity, muscle and bone health, respiratory health, and general wellness. Specific offerings address conditions such as constipation, hyperacidity, asthma, and colds, while also covering female, male, and mother-and-child wellness. The company utilizes in-house know-how from Sandu Brothers Private Limited for production and distributes its goods, including immunity kits and power herbs, through e-commerce marketplaces. Sandu Pharmaceuticals is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Sandu Pharmaceuticals stock

EBIT Margin (Operating Margin) of Sandu Pharmaceuticals is 3.87 % in 2026.

EBIT Margin (Operating Margin) of Sandu Pharmaceuticals changed from 3.36 % to 3.87 %, representing a 15.20% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT Margin (Operating Margin) Sandu Pharmaceuticals since 2006 – with annual values, charts, and detailed analysis.

EBIT Margin measures operating profitability as a percentage of revenue. It shows how much profit a company makes from operations before interest and taxes.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBIT Margin (Operating Margin)'s Sandu Pharmaceuticals with sector peers and the industry average to assess whether it is attractive.

To evaluate EBIT Margin (Operating Margin)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT Margin (Operating Margin).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — Sandu Pharmaceuticals

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — Sandu Pharmaceuticals